
Presenters
There is no shortage of COVID-19 coverage, but Mellon’s analysts tackle what should matter most to investors as they focus on the close of 2020 and prepare for 2021.

The discussion covers:
- Where are we in the process of getting vaccines approved?
- What have we learned about the impact of COVID-19 on the health care system?
- What trends and technologies will accelerate post-pandemic?